Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-09 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +56,250 56,250
2026-02-04 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +75,000 75,000
2025-12-22 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award +7,247 $1.38 $10K 9,482
2025-04-30 McCall Patrick CHIEF FINANCIAL OFFICER Option exercise +15,000 $0.18 $3K 67,071
2025-04-30 McCall Patrick CHIEF FINANCIAL OFFICER Option exercise · Series A Warrants (right to buy) −15,000 0
2025-04-27 McCall Patrick CHIEF FINANCIAL OFFICER Returned to the company · Series A Warrants (right to buy) −15,000 5,492
2025-04-27 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Series A Warrants (right to buy) +15,000 15,000
2025-04-27 McCall Patrick CHIEF FINANCIAL OFFICER Returned to the company · Series B Warrants (right to buy) −20,492 0
2025-04-27 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Series B Warrants (right to buy) +20,492 20,492
2025-02-05 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +343,000 343,000
2024-12-19 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +290,085 290,085
2024-10-04 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award +25,316 52,071
2024-10-04 McCall Patrick CHIEF FINANCIAL OFFICER Returned to the company · Series A Warrants (right to buy) −20,492 0
2024-10-04 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Series A Warrants (right to buy) +20,492 20,492
2024-10-04 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Series C Warrants (right to buy) +25,316 25,316
2024-09-04 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2024-02-07 McCall Patrick CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +189,000 189,000
2023-12-13 McCall Patrick Chief Financial Officer Grant or award +20,492 26,755
2023-12-13 McCall Patrick Chief Financial Officer Grant or award · Series A Warrants (right to buy) +20,492 20,492
2023-12-13 McCall Patrick Chief Financial Officer Grant or award · Series B Warrants (right to buy) +20,492 20,492

Page 1 of 2 · 27 trades